PT1490383E - Métodos e composições para identificar e caracterizar a hepatite c - Google Patents

Métodos e composições para identificar e caracterizar a hepatite c Download PDF

Info

Publication number
PT1490383E
PT1490383E PT03714097T PT03714097T PT1490383E PT 1490383 E PT1490383 E PT 1490383E PT 03714097 T PT03714097 T PT 03714097T PT 03714097 T PT03714097 T PT 03714097T PT 1490383 E PT1490383 E PT 1490383E
Authority
PT
Portugal
Prior art keywords
compositions
methods
hepatitis
characterizing
identifying
Prior art date
Application number
PT03714097T
Other languages
English (en)
Inventor
Carol Holland-Staley
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Publication of PT1490383E publication Critical patent/PT1490383E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
PT03714097T 2002-03-11 2003-03-11 Métodos e composições para identificar e caracterizar a hepatite c PT1490383E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11

Publications (1)

Publication Number Publication Date
PT1490383E true PT1490383E (pt) 2009-05-25

Family

ID=28041784

Family Applications (3)

Application Number Title Priority Date Filing Date
PT03714097T PT1490383E (pt) 2002-03-11 2003-03-11 Métodos e composições para identificar e caracterizar a hepatite c
PT08000552T PT1947104E (pt) 2002-03-11 2003-03-11 Métodos e composições para identificação e caracterização de hepatite c
PT08014584T PT2014671E (pt) 2002-03-11 2003-03-11 Métodos e composições para identificar e caracterizar a hepatite c

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT08000552T PT1947104E (pt) 2002-03-11 2003-03-11 Métodos e composições para identificação e caracterização de hepatite c
PT08014584T PT2014671E (pt) 2002-03-11 2003-03-11 Métodos e composições para identificar e caracterizar a hepatite c

Country Status (9)

Country Link
US (3) US20070172926A1 (pt)
EP (3) EP1947104B1 (pt)
AT (3) ATE423785T1 (pt)
AU (2) AU2003218111B8 (pt)
DE (2) DE60326327D1 (pt)
DK (3) DK1947104T3 (pt)
ES (3) ES2346717T3 (pt)
PT (3) PT1490383E (pt)
WO (1) WO2003077729A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE423785T1 (de) 2002-03-11 2009-03-15 Lab 21 Ltd Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c
US20080207760A1 (en) * 2005-04-11 2008-08-28 Achillion Pharmaceuticals, Inc. Pharmaceutical Compositions For and Methods of Inhibiting Hcv
US20090042814A1 (en) * 2005-10-14 2009-02-12 Ivan Petyaev Treatment and Diagnosis of Obligate Intracellular Pathogens
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20080015787A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
US20080015835A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
EP2463390A1 (en) 2006-10-20 2012-06-13 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS5B genomic region
WO2008046923A2 (en) * 2006-10-20 2008-04-24 Innogenetics N.V. Methodology for analysis of sequence variations within the hcv ns3/4a genomic region
WO2009059021A2 (en) * 2007-10-30 2009-05-07 Intermune, Inc. Hcv genotyping and phenotyping
RS51849B (en) * 2007-10-31 2012-02-29 Debiopharm S.A. EXAMINATION OF A SOON FULL GENOMA RESISTANCE TO HCV DRUG
WO2011151405A1 (en) 2010-06-04 2011-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
EP2721183A4 (en) 2011-06-20 2015-09-02 Siemens Healthcare Diagnostics REAGENTS AND METHODS OF DETECTING HCV VIRUS
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
ES2012739T5 (es) 1987-11-18 2001-12-01 Chiron Corp Diagnosticos para nanbv.
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (en) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
RU2148587C1 (ru) * 1991-06-24 2000-05-10 Чирон Корпорейшн Полипептид и способ его получения, реагент для иммуноанализа, способ определения присутствия антител и способ индукции иммунного ответа
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
ATE552340T1 (de) * 1993-04-27 2012-04-15 Innogenetics Nv Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
ES2231773T3 (es) * 1993-05-05 2005-05-16 Common Services Agency Virus de la hepatitis c de tipo 4, 5 y 6.
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
EP1012334A4 (en) * 1997-07-30 2004-12-29 Virologic Inc COMPOSITIONS AND METHODS FOR DETERMINING SENSITIVITY AND RESISTANCE TO ANTIVIRAL DRUGS, AND SCREENING FOR ANTIVIRAL DRUGS
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
CA2406140A1 (en) * 2000-04-18 2001-10-25 Virco Bvba Methods for measuring drug resistance
DK1296998T3 (da) * 2000-05-23 2011-12-12 Univ Washington HCV-varianter
AU2001282417A1 (en) * 2000-07-24 2002-02-05 Institute Of Molecular & Cell Biology Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
ATE423785T1 (de) 2002-03-11 2009-03-15 Lab 21 Ltd Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c

Also Published As

Publication number Publication date
US20120322051A1 (en) 2012-12-20
EP1947104A3 (en) 2009-04-08
EP1490383A4 (en) 2005-12-21
EP1490383A2 (en) 2004-12-29
US20070172926A1 (en) 2007-07-26
EP2014671A1 (en) 2009-01-14
AU2008249300B2 (en) 2012-08-16
DE60332781D1 (de) 2010-07-08
WO2003077729A3 (en) 2004-06-03
DK1947104T3 (da) 2012-08-06
EP2014671B1 (en) 2010-05-26
ES2346717T3 (es) 2010-10-19
ATE423785T1 (de) 2009-03-15
EP1490383B1 (en) 2009-02-25
DK1490383T3 (da) 2009-06-08
ATE556084T1 (de) 2012-05-15
AU2003218111B8 (en) 2008-11-20
EP1947104A2 (en) 2008-07-23
PT2014671E (pt) 2010-06-16
US20090047663A1 (en) 2009-02-19
WO2003077729A2 (en) 2003-09-25
AU2008249300A1 (en) 2008-12-18
DE60326327D1 (de) 2009-04-09
PT1947104E (pt) 2012-08-09
ES2321498T3 (es) 2009-06-08
EP1947104B1 (en) 2012-05-02
WO2003077729A9 (en) 2004-04-22
DK2014671T3 (da) 2010-09-20
US8173795B2 (en) 2012-05-08
ATE469162T1 (de) 2010-06-15
AU2003218111A1 (en) 2003-09-29
ES2386742T3 (es) 2012-08-28
AU2003218111B2 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
PT1490383E (pt) Métodos e composições para identificar e caracterizar a hepatite c
DE60233462D1 (de) Neue Zusammensetzung und Methode zur 'hot start' Nukleinsäureamplifizierung
EP1961826A3 (en) A method for direct nucleic acid sequencing
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DE60041940D1 (de) Oligonukleotidprimer zur effizienten Detektion von Hepatitis C Virus (HCV) sowie Verwendungsverfahren
EP2272952B8 (en) Thermostable or thermoactive DNA polymerase with attenuated 3'-5' exonuclease activity
IL221602A0 (en) A method of detecting and/or identifying adeno-associted virus (aav) sequences and isolating novel sequences identified thereby
JP2003524416A5 (pt)
CA2421767A1 (en) Method and kit for determining human geographic or population origin
DE60230672D1 (de) Nukleinsäureanreicherung
KR100626578B1 (ko) 열안정성 ｔａｑ 폴리머라제 절편
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
ATE485391T1 (de) Zusammensetzungen, methoden und testssysteme zur bestimmung der präsenz von cryptosporidium organismen in einer testprobe
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
DE60041912D1 (de) Polymorphe marker des lsr-gens
EP1736543A4 (en) METHOD FOR DETECTING AND QUANTIFYING ENDOGENIC WHEAT DNA SEQUENCE
CA2451592A1 (en) Marker assisted selection of bovine for improved milk composition
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
DE60024679D1 (de) Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis
EP1688492A4 (en) METHOD AND KIT FOR ASSESSING THE SIDE EFFECT THROUGH PACLITAXEL THERAPY
Bouma et al. Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods